Annales françaises d'anesthèsie et de rèanimation
-
Ann Fr Anesth Reanim · Jan 2000
Comparative Study[Postoperative mortality a university Department of General Surgery: incidence of cardiac-related deaths].
To evaluate the incidence of cardiac deaths following noncardiac nonvascular surgery. ⋯ This study suggests that cardiac morbidity is a rare cause of death after noncardiac nonvascular surgery.
-
Ann Fr Anesth Reanim · Jan 2000
[Sciatic nerve block: an new lateral mediofemoral approach. The value of its combination with a "3 in 1" block for invasive surgery of the knee].
To describe a new midfemoral lateral approach for the sciatic nerve block. Its combination with the "3 in 1" block was tested for postoperative analgesia following major surgery of the knee. ⋯ The new lateral midfemoral sciatic block is easy to master. Combined with a continuous "3 in 1" block, it provides excellent analgesia during the early postoperative period after major surgery of the knee.
-
Ann Fr Anesth Reanim · Jan 2000
Case Reports[Acute pulmonary edema associated with the use of beta2-mimetic tocolytic agents].
A case of severe pulmonary oedema during beta2-adrenergic agonist tocolytic therapy (salbutamol) in a pregnant woman admitted for preterm labor at 32 weeks of amenorrhoea is reported. Echocardiography and haemodynamic investigations did not show any left ventricular systolic or diastolic dysfunction. ⋯ The diagnosis is considered in pregnant patients presenting with respiratory distress, associated with or following tocolytic therapy. Anaesthetic management of patients treated with a beta2-adrenergic agonist should take into consideration the delay between discontinuation of tocolytic therapy and anaesthetic induction, as well as volume expansion.
-
Ann Fr Anesth Reanim · Dec 1999
Multicenter Study Clinical Trial[Pharmacodynamics and safety of mivacurium in infants and children under halothane-nitrous oxide anesthesia].
To determine pharmacodynamic effects and safety of mivacurium in paediatric patients. ⋯ Following 0.2 mg.kg-1 of mivacurium in patients aged between three months to eight years, a complete blockade occurs with a rapid onset time and a short duration of action, without significant cardiovascular effect.